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Abstract
Background: In pregnancy, untreated chlamydia infection has been associated with adverse outcomes for both
mother and infant. Like most women, pregnant women infected with chlamydia do not report genital symptoms,
and are therefore unlikely to be aware of their infection. The aim of this study was to determine the acceptability
of screening pregnant women aged 16-25 years for chlamydia as part of routine antenatal care.
Methods: As part of a larger prospective, cross-sectional study of pregnant women aged 16-25 years attending
antenatal services across Melbourne, Australia, 100 women were invited to participate in a face-to-face, semi
structured interview on the acceptability of screening for chlamydia during pregnancy. Women infected with
chlamydia were oversampled (n = 31).
Results: Women had low levels of awareness of chlamydia before the test, retained relatively little knowledge after
the test and commonly had misconceptions around chlamydia transmission, testing and sequelae. Women
indicated a high level of acceptance and support for chlamydia screening, expressing their willingness to
undertake whatever care was necessary to ensure the health of their baby. There was a strong preference for urine
testing over other methods of specimen collection. Women questioned why testing was not already conducted
alongside other antenatal STI screening tests, particularly in view of the risks chlamydia poses to the baby. Women
who tested positive for chlamydia had mixed reactions, however, most felt relief and gratitude at having had
chlamydia detected and reported high levels of partner support.
Conclusions: Chlamydia screening as part of routine antenatal care was considered highly acceptable among
young pregnant women who recognized the benefits of screening and strongly supported its implementation as
part of routine antenatal care. The acceptability of screening is important to the uptake of chlamydia screening in
future antenatal screening strategies.
Background
Genital Chlamydia trachomatis infection is one of the
most common bacterial sexually transmitted infection
(STI) worldwide [1]. Untreated chlamydia infection can
cause serious reproductive sequelae for women, includ-
ing pelvic inflammatory disease, tubal infertility, chronic
pelvic pain, and ectopic pregnancy [2,3].
In pregnancy, untreated chlamydia infection has been
associated with adverse maternal and neonatal out-
comes, including increased risk of miscarriage, postpar-
tum endometritis, premature rupture of the membranes
and preterm labour for the mother, and a risk of low
birth weight and transmission during the delivery to the
neonate, leading to conjunctivitis and pneumonitis [4-8].
Most women infected with chlamydia do not report
symptoms, and are therefore unlikely to be aware of
their infection [3].
Cross-sectional studies in developed countries have
shown chlamydia prevalence can be high among
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women under 20 years of age [9,10]. In a UK study by
Norman et al (2004) the prevalence of chlamydia among
pregnant women under the age of 20 years attending
antenatal clinics was 12.1% [11]. In a recent Australian
study by Chen et al (2009), the prevalence of chlamydia
in a cross section of pregnant women aged 16 to
20 years attending antenatal services across Melbourne
was 6.4% [12].
The US Preventative Services Task Force has found
evidence of improved pregnancy and birth outcomes for
pregnant women who are treated for chlamydia and
recommend screening of all pregnant women aged
24 years and younger [13]. A number of countries
recommend the screening of pregnant women aged 25
and less, however the extent to which this screening is
undertaken varies within and between countries [14-16].
There are however, no randomized controlled trials on
the benefits and outcomes of screening for chlamydia
during pregnancy. Currently in Australia, pregnant
women are generally not screened for chlamydia as part
of their routine antenatal care although selective screen-
ing of teenage girls occurs at some services.
Few published data are available on whether young
pregnant women would find screening for chlamydia an
acceptable part of routine antenatal care [17,18]. The
acceptability of chlamydia screening during pregnancy
would be critical in the success of programs aimed at
improving screening of this population of women. The
aim of this study was to determine the acceptability of
screening young pregnant women aged 16-25 years for
chlamydia as part of their routine antenatal care.
Methods
Women were recruited from four major antenatal ser-
vices across Melbourne (population 3.9 million) [19]
Victoria, Australia between December 2006 and July
2007: the Royal Women’s Hospital, Mercy Hospital for
Women, Sunshine Hospital and Southern Health.
Women were recruited as part of a larger cross sectional
study examining the prevalence and factors associated
with chlamydia in pregnancy [12]. As part of the larger
cross sectional study, women were recruited from a
broad range of areas across Melbourne to capture the
socio-economic, cultural and geographical diversity of
the population. In this study, any women aged 16-25
attending services were eligible for the study. At the
time of recruitment, women were provided information
and informed by a research nurse about chlamydia and
the associated adverse maternal and neonatal outcomes
of untreated chlamydia infection. Women were asked to
provide a first void urine specimen for chlamydia testing
by polymerase chain reaction and complete a brief ques-
tionnaire providing basic demographic information,
recent sexual behaviour, genital symptoms and recent
antibiotic use. At the time of recruitment, routine
antenatal screening for chlamydia was not offered at any
of the participating services.
At the time of recruitment, women were informed and
provided consent to be approached at a later date for an
interview on the acceptability of screening. Women
were approached for the acceptability interview after
they had been tested for chlamydia, received their test
results, where applicable, been treated for chlamydia
with single-dose oral azithromycin (1.0 g) and had suffi-
cient time to notify their partner/s.
Women returning for an appointment at all four ser-
vices were approached opportunistically to participate in
the acceptability interview following their scheduled
appointment. Women’s disease status was known in
advance to allow researchers to approach all chlamydia
infected women. To participate in the sub-study women
were required to have a reasonable command of English.
Those who consented were interviewed in a private
room within the service. People accompanying the parti-
cipants were asked to remain in the waiting room while
the interview was conducted. Participants were offered
two cinema tickets for their participation in the
interview.
All interviews were conducted face-to-face by JB using
a semi-structured interview schedule that contained 21
specific questions, most of which were open ended and
allowed the interviewer to probe for further clarification
or questioning. The interview schedule consisted of pri-
marily open ended questions about participants knowl-
edge of chlamydia, self-assessed on entry to the larger
study and again at the time of the acceptability inter-
view, their experience and opinion on antenatal screen-
ing, specimen collection and receiving results, the
experience of testing and treatment (if applicable) and
informing partners (Additional file 1). Questions were
also slightly modified depending on whether the partici-
pant had received a positive or negative test result. On
average, interviews took approximately 10 to 15 minutes
to complete.
All interviews were digitally recorded, transcribed ver-
batim and imported into N-Vivo 8 for thematic analysis.
All data were de-identified to protect confidentiality.
JB and DD reviewed the transcripts separately before
meeting to discuss codes and emergent and recurrent
themes. A coding system was derived from the interview
schedule questions and themes arising recurrently in the
interviews. Similar codes and initial themes were
grouped into broader topics i.e. knowledge of chlamydia,
acceptability of screening, and examined for similarities
and differences. Ten percent of transcripts were further
reviewed independently by MTS to confirm coding and
themes. Demographic data were partially obtained from
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of the larger study. Analyses of demographic data were
conducted using SPSS 17.0.
Ethical approval for the study was granted from
Research Ethics Committee at each of the four hospitals
and The University of Melbourne.
Results
A total of 101 women were invited to take part in the
study, of which 100 participated (99% participation rate).
One 24 year old woman who had tested positive for
chlamydia declined to participate. Of the 100 women
who participated, 69 had tested negative for chlamydia
and 31 positive for chlamydia. The characteristics of
participants are shown in Table 1.
Women who tested positive for chlamydia were more
likely to be under 20 years of age (32% versus 15%, p =
0.04), have had a new sexual partner in the last 12
months (26% versus 7%, p = 0.01), had two or
more partners in the last 12 months (44% versus 9%,
p < 0.01) and be unmarried or single (77% versus 49%;
p = 0.01).
Women’s knowledge of chlamydia
In general, women had low levels of awareness of chla-
mydia prior to the study. Two thirds of women had
never heard of chlamydia before or only knew of it by
name, with one third aware it was an STI but unable to
provide any further details. Only five women knew it
w a sa nS T Ia n dw e r ea b l et op r o v i d eas m a l la m o u n to f
detail about the infection:
...I didn’t know anything about it and then when [the
research assistant] told me to read about it, and I read
i t ,a n dt h e nw h e nIf o u n do u tIw a sp o s i t i v ei tj u s t
shocked me [because] I didn’t even know I could have it.
(KS387)
...I only knew that it was an STD, I didn’tk n o ww h a t
it was, or any specifics about symptoms or anything like
that. (JH241)
Women’s main sources of information were school sex
education, friends, women’s magazines or through pre-
vious testing. Misconceptions around chlamydia trans-
mission, testing and sequelae were common, and
included beliefs that: testing was routinely undertaken
concurrently with pap smears; transmission could occur
from towels, toilet seats or through non-sexual means;
chlamydia infection was ‘like herpes’;m e na r et h e‘car-
riers’; and that it is an untreatable infection.
...Actually I think you can catch chlamydia non-sexu-
ally can’t you? (SA222)
...What I heard [about chlamydia previously] was com-
pletely different to what I actually found out about [it]...I
just thought it would show up in a pap smear. (ME465)
A number of women associated risk of infection with
high numbers of sexual partners or sexual promiscuity,
believing that women with only one or two lifetime sex-
ual partners were not at risk of infection.
Of note, women retained little knowledge even after
being informed and tested for chlamydia. Women, who
had been tested previously for chlamydia, or tested posi-
tive as part of the study, were more likely to retain
information.
Acceptability of screening
All women, regardless of their relationship status, dura-
tion of pregnancy or whether they had been tested pre-
viously for chlamydia, supported testing for chlamydia
as part of their routine antenatal care. Overall, women
felt that being tested for chlamydia was ‘no big deal’,
particularly given the number of routine tests and
checks undertaken as part of their antenatal care and
supported screening for all pregnant women regardless
of age.
...Well you [get] tested for everything else, all these
other things that can harm the baby, don’ty o u ?Im e a n
there’s a test for Hep B, HIV, all these other things that
can harm the baby. I mean if chlamydia is an infection
Table 1 Characteristics of pregnant females aged
16-25 years (n = 100)
Participant characteristics % or Median [range]
Age 22 [16-25]
Weeks gestation 22 [6-42]
Place of birth
Australia 69
Outside Australia 31
Aboriginal or Torres Straight Islander 3
Education level
Year 9 13
Year 10-12 55
Tertiary 32
Relationship status
Married 42
Living with partner 37
Not living with partner 16
No partner 5
Tested previously for chlamydia 9
Chlamydia test result
Negative 69
Positive 31
New sex partners in last 12 months
Yes 13
No 87
Number of sex partners last 12 months
1 partner 80
2-3 partners 18
4+ partners 2
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to put your baby through any [potential harm]? (MB304)
...I’m not just saying it but I’d recommend it. I can’t see
any downfalls to it...you can if you don’t have it [the
test], there’s a lot of downfalls, but “Have a test”,i t ’sn o
biggie. (CK108)
...I’d want to know about it definitely, so that I didn’t
p a s si to na n da l s os ot h a tIc o u l dg e tt r e a t e df o ri t ,
especially if you don’t know it is there... (PA196)
Nearly all women reported that they strongly preferred
urine testing over any other forms of specimen collec-
tion such as vaginal or cervical swabs because it was
quick, easy and non-invasive.
...it’s just simple and easy and the other ways are a bit
uncomfortable. (LD203)
...It’s convenient, it’s not too invasive, it’s something you
can go and do privately, it’s pretty routine. (JH241)
Almost all women bar one reported that they would
recommend chlamydia testing to a friend who was
pregnant.
...I was actually talking to my sister-in-law about that
chlamydia today, this morning, because she’sp r e g n a n t
too and she’s definitely going to get that [test] done too.
(AG244)
...I’ve actually already recommended it, like to my
younger cousins who are more sexually active than me,
and they are not pregnant. Because it’ss o m e t h i n gy o u
do, if they don’t do it now they are not going to be able
to fall pregnant, there is that chance. (MS465)
Motivation for supporting screening
The main motivating factor in the acceptability of
screening was concern for the health of the baby. The
safety of the baby was paramount, with women report-
ing they would undertake whatever care was necessary
to ensure their baby was born without any health pro-
blems or complications. Women felt the benefits of
screening for themselves and their babies far outweighed
any potential concerns about testing.
...Oh anything for the baby, as long as my baby’s
healthy I will do anything for my baby. I wouldn’tr i s k
my baby having an infection. (RA926)
Women’s main concern about testing for chlamydia
was whether testing and treatment could potentially
harm the baby. A few women reported that they were a
little embarrassed about being asked to take the test or
a little nervous or apprehensive about the treatment,
however once assured that testing and treatment was
safe during pregnancy, all women were happy to under-
take testing.
...You want to get it done [test] to see if you have chla-
mydia but you think, ‘My God, what about the baby?’,
so you don’t want to do any harm to your baby either.
(AM243)
...That was my main concern, that I was safe to be
treated while I was pregnant without risking anything
happening to the baby, and as long as that was fine
I was willing to be treated while I was pregnant...just as
long as it didn’t harm the baby. (TA1061)
Women commonly questioned why screening was not
already being done alongside other routine antenatal
STI screening given the adverse outcomes for both
mother and baby.
Trust in their physician
Women tended to implicitly trust their physician to
know what was best for them, and their baby, stating
that they would undertake whatever care or testing was
recommended by their physician during pregnancy.
While it could be uncomfortable or embarrassing at
first, women reported that they would not mind their
physician asking for a sexual history to assess their risk
o fc h l a m y d i am a i n l yb e c a u s et h e yw e r ep r e g n a n ta n d
therefore obviously sexually active, the request would be
for pregnancy related medical reasons, the information
w o u l db ec o n f i d e n t i a la n db e c a u s et h e yw e r eg e n e r a l l y
in committed, monogamous relationships.
...It’sf i n ef o rm eb e c a u s ei ft h ed o c t o rt h i n k sh eo rs h e
needs that kind of information to enable them [to] make
any recommendation then it is OK to ask this question.
(CW249)
A few women noted that if they were single, had their
partner in the room or felt that they were being judged
by their physician they would not be comfortable in
providing a sexual history.
...Um...oh twelve months ago I probably wouldn’t have
liked being asked that question but considering I’ve been
with my partner and only him for the last 12 months, it
doesn’tb o t h e rm e .I tc o u l db eab i ti n t r u s i v ea n dy o u
could feel like it could be a bit demeaning cos people
tend to judge you if you’ve had a few. (SS335)
Chlamydia infected women
Chlamydia infected women did not noticeably differ from
uninfected women in their responses and attitude toward
screening, other than voicing noticeably stronger support
for screening as a result of their diagnosis and being
more likely to retain information about chlamydia than
uninfected women. Women who tested positive for chla-
mydia had mixed reactions; however, most felt relief and
gratitude at having had chlamydia detected. While some
women reported feeling shocked at first, very few experi-
enced strong, negative reactions around the diagnosis.
They took a pragmatic approach to the diagnosis,
gathering information about chlamydia and resolving to
get treatment quickly for the health of themselves and
the baby. The majority of women expressed relief and
gratitude at having been diagnosed and treated.
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wise I wouldn’t have a clue. I’m really glad that I found
out now and got treatment and stuff and hopefully it’s
gone. (TM1061)
...I’m just glad that, you know, I seen you, so that
I found out that I had [the] infection and it’sg o i n gt o
be treated now, so thank you. (KK529)
Most women sought treatment quickly and reported
no adverse side effects to the treatment for chlamydia
(single-dose oral azithromycin 1.0 g). Of the few women
who reported side effects, the most common side effects
included nausea, vomiting or stomach cramps. Overall,
women’s main concern around treatment was again the
safety of the baby.
...that was my main concern, that it was safe to be
treated while I was pregnant without risking anything
happening to the baby and as long as that was fine
I was willing to be treated while I was pregnant... (TM
1061)
The exception was one woman who was very compla-
cent about treatment, reporting that she had not yet
been treated for chlamydia as it would be an inconveni-
ence and she did not feel she was infected.
...I really don’t know [if I will get treated], it’s really
inconvenient for me because I have a little baby and
there if nobody to take care of [him/her].... I am not wor-
ried at all. I don’tf e e lIh a v ea ni n f e c t i o n .Y e a hId o
[believe the test] but I’m just not worried about it.
(NA701)
Two women reported that their partners had not
sought treatment or it was unlikely they had been trea-
ted despite being informed of their risk of chlamydia.
Partner notification and support
The majority of women informed their partners of their
chlamydia diagnosis and reported high levels of partner
support. In general, women were comfortable informing
their partner of their diagnosis because they were in
committed relationships, felt they had a moral obligation
to stop re-infection and transmission to others and were
confident that their partner would be supportive.
. . . Id i s c u s s e di tw i t hh i mo n c eIf o u n do u tt h a tIw a s
infected...um, because I thought he had a right to know
because he would have been infected as well and we
both went off and got the antibiotics and stuff like that...
(TM 1061)
...it was easy for me because I’ve been with my partner
for a while and, you know, we knew everything was
alright and, you know, we could have had this chlamy-
dia before we even met, so we had no problems. He went
to a GP that night after I found out and got tablets
straight away as well, so I had no problems, we had no
problems with each other. (AS354)
Overall, women reported that neither themselves, nor
their partners reacted angrily to the diagnosis or blamed
one another; however, a couple of women did question
their partners following the diagnosis.
...He was pretty fine with it, he just had to get treat-
ment straightaway. I did question [him on] a lot of stuff
but it was OK and then we had this honesty thing, how
he had to tell me everything...yeah it turned out good.
(KS387)
...I actually rang him and told him that, well, this is
the case, I’ve got it, questioned him a little bit. But at
the end of the day we said ‘Well, I need to get my anti-
biotics, you need to go to the doctors, and it took him a
while, and I said “Well, there’sn os e xi nb e t w e e n ” and
so he went to the doctors. So once I told him he was
pretty much as shocked as I was and um, yeah, we both
sort of discussed it, it was easy to fix and yeah, we were
lucky we did get it picked up when we did. (MS465)
A few women did experience some negativity around
notifying their partners, mainly in terms of their part-
ners showing little care or interest in the diagnosis or
not believing them at all.
...Well I got in contact with him [and] he didn’t really
seem too “Oh God, you know, that’sb a d ”,i t ’sj u s t ,l i k e
he didn’t really care, said it’s not his problem in other
words, that’s how he made it sound. I told him that you
know, you can go and get it checked up, I spelt it [out] to
h i mo v e rt h ep h o n es ot h a th ec o u l dg ot ot h ed o c t o r ,
and he said “Nah, you know, what for?” He said, “I’m
alright”. (MH262)
Overall, at the time of the interview, three women,
two single and one in a relationship, reported that they
had not informed their partner about their risk of chla-
mydia, either because the relationship had broken down,
their partner was overseas or because of infidelity on
their part.
Discussion
In this study we found that chlamydia screening, as part
of routine antenatal care, was considered highly accepta-
ble among young pregnant women, who were strongly
motivated by concern for the health of their baby and
willing to undertake whatever care was necessary to
ensure the safety of their baby. Women commonly
questioned why chlamydia testing was not already being
undertaken as part of routine, antenatal care given the
possible complications of untreated infection for mother
and baby. Urine testing was preferred as is it was quick,
easy and non-invasive. As previous studies have shown
[9,10,12,20,21], chlamydial infection was associated with
a young age, more than one recent sexual partner and
unmarried status. Women who tested positive for chla-
mydia were relieved and grateful to have been diagnosed
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ner support.
Strengths and limitations
There are few data on the acceptability of chlamydia
screening among pregnant women. To our knowledge,
this is the first study to specifically explore the accept-
ability of screening for chlamydia after test results are
received among young, pregnant women as part of rou-
tine antenatal care. Previous studies have focused on
testing method preferences of pregnant women [22,23]
and the acceptability of screening among pregnant teen-
agers using self-administered vaginal swabs [17].
Strengths of this study include the number of women
interviewed, inclusion of chlamydia infected women and
the high participation rate (99%).
A limitation of the study was the depth of data col-
lected. Traditionally, conventional qualitative interviews
take between 30 to 60 minutes, with schedules guided
by broad research topic/s, allowing for open, flexible in-
depth discussion of the topic/s. While our questions
were predominantly open-ended, we chose to use an
interview schedule of 21 fixed questions to ensure we
collected specific information relevant to our topic. The
fixed nature of the interview schedule and interviewing
women ‘on the spot’, meant interviews were relatively
short and lacked the depth of conventional qualitative
interviews as women were limited for time; however,
this also resulted in a high participation rate.
Further limitations of our study were that women
were only recruited from sites in Melbourne, Australia,
were not randomly selected, and were all in the 16-25
year age group, therefore their views and experiences of
antenatal screening for chlamydia may not be represen-
tative of pregnant women elsewhere.
Past research has shown that women are more likely
to find chlamydia screening acceptable if they are well
informed of the serious sequelae of untreated chlamydia,
understand that it is a common condition which is often
asymptomatic, and are aware it can be easily treated
[24]. A personal factor also found to facilitate women’s
acceptance of screening is a belief they may be pregnant
[24]. Common barriers to chlamydia testing include:
denial by women of sexual activity or risk of infection; a
reluctance to be tested because of moral connotations
and stigma associated with a positive diagnosis, feelings
of shame, guilt, embarrassment and anger; a fear and
anxiety around future reproductive health and the
effects of a positive diagnosis on partner relationships;
concerns around privacy and confidentiality; and the
time, cost and method of sample collection [24].
It is likely that chlamydia testing was highly acceptable
to pregnant women in this study because the test was sim-
ple, safe and non-invasive [10,22,23]; one of a number of
screening tests undertaken during pregnancy and women’s
concern for the health of their baby was paramount. Inter-
estingly, the same levels of shame, guilt, fear, anger and
embarrassment reported by non-pregnant women follow-
ing a positive diagnosis and the notification of partners
were generally not experienced by women in this study
[24-29]. While reactions were mixed, most women took a
very pragmatic approach to their diagnosis, treatment and
the notification of partners. Negative reactions to the diag-
nosis and partner notification were experienced by few
women, with most reporting high levels of partner sup-
port. This is possibly because most women were sexually
active within a committed long term relationship which
provided them with a sense of security, support, high
levels of trust and non-judgment from both partners and
health professionals. Women in this study certainly
seemed to feel less pressure around the moral connota-
tions and stigma commonly associated with a positive
diagnosis. Interestingly, the few single women in the study
reported similar views and experiences around testing and
treatment, suggesting that the health of the baby also took
precedence over any stigma related concerns single
women may have had.
While screening for chlamydia was highly acceptable
among women in this study, if screening is to be broadly
accepted and implemented as part of antenatal care,
further education and awareness is required. Women in
this and previous studies [17,30] have commonly shown
low levels of awareness about chlamydia. Accurate infor-
mation and education plays a major role in the accept-
ability of testing for chlamydia, with women more likely
to accept testing if they know chlamydia is a serious,
common infection that is often asymptomatic and can
cause significant reproductive sequelae [24].
Conclusions
Chlamydia testing using urine specimens was highly
acceptable among young pregnant women in this study.
For antenatal chlamydia testing to be broadly accepted it
is imperative pregnant women are well informed about
chlamydia and the benefits of screening. The acceptability
of testing is vital in the successful uptake of screening and
informing appropriate antenatal screening strategies.
Additional material
Additional file 1: Interview schedule. Schedule used to interview
women participating in the study.
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